Abstract
Hepatitis C virus (HCV) infects an estimated 170 million people globally and persistent infection within the liver is the usual outcome of infection. The resulting liver disease leads to substantial morbidity and to date no vaccine exists. Furthermore the treatments available are frequently ineffective. A minority of those exposed will however successfully control the virus and the factors that dictate this remain elusive. The events that occur in the immediate and early phase post exposure are thought to play a crucial role in determining the outcome and virus specific T cells have a confirmed role in directing the immune response towards a successful outcome. An understanding of the T cell responses and the strategies, which allow the virus to evade these responses in the majority, is an essential prerequisite both for vaccine design and the development of therapeutic agents. We review here the characteristics of the cellular immune responses in acute infection and how the virus manages to undermine these responses and establish chronicity.
Keywords: T cell, acute hepatitis C, immunology, cell-mediated, escape mutation
Current Pharmaceutical Design
Title: Cellular Immunity and Acute Hepatitis C Infection
Volume: 14 Issue: 17
Author(s): K. Fitzmaurice and P. Klenerman
Affiliation:
Keywords: T cell, acute hepatitis C, immunology, cell-mediated, escape mutation
Abstract: Hepatitis C virus (HCV) infects an estimated 170 million people globally and persistent infection within the liver is the usual outcome of infection. The resulting liver disease leads to substantial morbidity and to date no vaccine exists. Furthermore the treatments available are frequently ineffective. A minority of those exposed will however successfully control the virus and the factors that dictate this remain elusive. The events that occur in the immediate and early phase post exposure are thought to play a crucial role in determining the outcome and virus specific T cells have a confirmed role in directing the immune response towards a successful outcome. An understanding of the T cell responses and the strategies, which allow the virus to evade these responses in the majority, is an essential prerequisite both for vaccine design and the development of therapeutic agents. We review here the characteristics of the cellular immune responses in acute infection and how the virus manages to undermine these responses and establish chronicity.
Export Options
About this article
Cite this article as:
Fitzmaurice K. and Klenerman P., Cellular Immunity and Acute Hepatitis C Infection, Current Pharmaceutical Design 2008; 14 (17) . https://dx.doi.org/10.2174/138161208784746806
DOI https://dx.doi.org/10.2174/138161208784746806 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oral Tolerance Induction for Human Food Allergy
Inflammation & Allergy - Drug Targets (Discontinued) From Natural Products to Small Molecule Ketone Histone Deacetylase Inhibitors: Development of New Class Specific Agents
Current Pharmaceutical Design Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Current Pharmaceutical Design Essential Roles of Toll-Like Receptors in Atherosclerosis
Current Medicinal Chemistry Dimerization and Ion Binding Properties of S100P Protein
Protein & Peptide Letters Effects of Statins on Bone Markers, Bone Mineral Density and Fractures. Possible Role in Osteoporosis Treatment
Current Pharmaceutical Analysis CC-Chemokine Receptors in Chronic Obstructive Pulmonary Disease
Inflammation & Allergy - Drug Targets (Discontinued) Further Vitamin D Analogs
Current Vascular Pharmacology Neurodegeneration in the Pathogenesis of Diabetic Retinopathy: Molecular Mechanisms and Therapeutic Implications
Current Medicinal Chemistry Gene Therapy to Improve High-Density Lipoprotein Metabolism and Function
Current Pharmaceutical Design Wound Healing Microenvironmental Cues: From Tissue Analogs to Skin Regeneration
Current Tissue Engineering (Discontinued) Patent Selections
Recent Patents on Drug Delivery & Formulation Acute Hepatitis C: Clinical Aspects, Diagnosis, and Outcome of Acute HCV Infection
Current Pharmaceutical Design Structure and Function of MPN (Mpr1/Pad1 N-terminal) Domain- Containing Proteins
Current Protein & Peptide Science Oxidative Stress During Myocardial Ischaemia and Heart Failure
Current Pharmaceutical Design Erratum
Mini-Reviews in Medicinal Chemistry Fusion Partners as a Tool for the Expression of Difficult Proteins in Mammalian Cells
Current Pharmaceutical Biotechnology Zoledronic Acid -a Multiplicity of Anti-Cancer Action
Current Medicinal Chemistry Study of SARS-nCoV2 Indian Isolates Gaining Insights into Mutation Frequencies, Protein Stability and Prospective Effect on Pathogenicity
Coronaviruses The Mechanism of Mucus Production in Bronchial Asthma
Current Medicinal Chemistry